1. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19. (28th August 2020) Authors: Sahebnasagh, Adeleh; Saghafi, Fatemeh; Safdari, Mohammadreza; Khataminia, Masoud; Sadremomtaz, Afsaneh; Talaei, Zeinab; Rezai Ghaleno, Hassan; Bagheri, Mahdi; Habtemariam, Solomon; Avan, Razieh Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 45:Number 6(2020) Page Start: 1515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗